Catalyst Clinical Research Acquires Aptus Clinical To Accelerate European Expansion, Broaden Client Services, And Enhance Patient Impact
Catalyst Clinical Research Acquires Aptus Clinical To Accelerate European Expansion, Broaden Client Services, And Enhance Patient Impact
05/04/22, 12:01 PM
Location
wilmingtonIndustry
biotechnology
health care
Today, Catalyst Clinical Research, a market-leading provider of clinical research services, announced a strategic acquisition of Aptus Clinical to expand the geographic reach of the two companies, and to enhance patient access to advanced, life-changing therapies. Together, the two entities will become one multi-region clinical research organization with an accelerated growth trajectory in both the U.S. and Europe.
Company Info
Location
Wilmington, North Carolina, United States
Company info
Catalyst Clinical Research, a clinical research organization (CRO), provides highly customizable solutions to the global biopharmaceutical and biotechnology industries through two established solutions: Catalyst Oncology and Catalyst Flex. Catalyst Oncology provides full-service specialty oncology CRO offerings while Catalyst Flex delivers multi-therapeutic customer- or Catalyst-managed functional (FSP) services. With more than 1,000 staff and several offices in the United States, Europe, and the Asia-Pacific region, Catalyst's flexible service model is built from more than a decade of listening to customers, devising customer-centric solutions, and helping customers advance their clinical studies by leveraging expert teams and innovative technologies.
